[go: up one dir, main page]

AU2002320079A1 - Vaccines, immunotherapeutics and methods of using the same - Google Patents

Vaccines, immunotherapeutics and methods of using the same

Info

Publication number
AU2002320079A1
AU2002320079A1 AU2002320079A AU2002320079A AU2002320079A1 AU 2002320079 A1 AU2002320079 A1 AU 2002320079A1 AU 2002320079 A AU2002320079 A AU 2002320079A AU 2002320079 A AU2002320079 A AU 2002320079A AU 2002320079 A1 AU2002320079 A1 AU 2002320079A1
Authority
AU
Australia
Prior art keywords
immunotherapeutics
vaccines
methods
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002320079A
Other languages
English (en)
Inventor
Jeong-Im Sin
David B. Weiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Publication of AU2002320079A1 publication Critical patent/AU2002320079A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002320079A 2001-06-11 2002-06-11 Vaccines, immunotherapeutics and methods of using the same Abandoned AU2002320079A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29733601P 2001-06-11 2001-06-11
US60/297,336 2001-06-11
PCT/US2002/018541 WO2002100345A2 (fr) 2001-06-11 2002-06-11 Vaccins, compositions immunotherapeutiques, et procedes d'utilisation

Publications (1)

Publication Number Publication Date
AU2002320079A1 true AU2002320079A1 (en) 2002-12-23

Family

ID=23145882

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002320079A Abandoned AU2002320079A1 (en) 2001-06-11 2002-06-11 Vaccines, immunotherapeutics and methods of using the same

Country Status (2)

Country Link
AU (1) AU2002320079A1 (fr)
WO (1) WO2002100345A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004112706A2 (fr) 2003-06-13 2004-12-29 The Trustees Of The University Of Pennsylvania Vaccins, agents immunotherapeutiques et leurs methodes d'utilisation
EP1699480B1 (fr) 2003-12-30 2011-06-15 Mologen AG Agent therapeutique antitumoral allogene
AU2012202094B2 (en) * 2005-08-30 2013-08-22 University Of Miami Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins
EP1919954B1 (fr) 2005-08-30 2016-10-19 University of Miami Immunomodulation des agonistes, des antagonistes et des immunotoxines du recepteur 25 du facteur de necrose tumorale (tnfr25)
SG178125A1 (en) 2009-08-03 2012-03-29 Univ Miami Method for in vivo expansion of t regulatory cells
KR20210041631A (ko) 2013-01-09 2021-04-15 유니버시티 오브 마이애미 TL1A-Ig 융합 단백질을 사용한 T 조절 세포의 조절을 위한 조성물 및 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090790A (en) * 1989-12-14 2000-07-18 Eriksson; Elof Gene delivery by microneedle injection
CA2161095A1 (fr) * 1993-04-20 1994-10-27 Solis Therapeutics, Inc. Methodes et produits pour le traitement d'individus contamines par des agents infectieux intracellulaires
DE69433013T2 (de) * 1993-05-27 2004-06-03 Entremed, Inc. Zubereitungen und verfahren für die behandlung von krebs und hyperproliferierenden krankheiten
US6197743B1 (en) * 1996-07-26 2001-03-06 The Trustees Of Boston University Compositions and methods for the treatment of viral disorders

Also Published As

Publication number Publication date
WO2002100345A2 (fr) 2002-12-19
WO2002100345A3 (fr) 2003-07-10

Similar Documents

Publication Publication Date Title
AU2003235707A1 (en) Immunogenic preparations and vaccines on the basis of mrna
AU2002336760A1 (en) Mutable vaccines
AU2002236159A1 (en) Immunogenic complex
IL162266A (en) Substituted 2-thio-3,5-dicyano-4- phenyl-6-aminopyridines and the use of the same
AU2003301066A1 (en) Al2o3-la2o3-y2o3-mgo ceramics, and methods of making the same
AU2002329873A1 (en) Halogenated calixpyrroles, calixpyridinopyrroles and calixpyridines, and uses thereof
AU2001256373A1 (en) Syringe and method for the use thereof
AU2002341511A1 (en) Macroporous gel, its preparation and its use
AU2002212049A1 (en) Novel silicone material, its preparation method and the use thereof
AU2002233407A1 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
AU2002238688A1 (en) Aryl carbamate derivatives, preparation and use thereof
AU2002320079A1 (en) Vaccines, immunotherapeutics and methods of using the same
AU2002236065A1 (en) Papillomavirus vaccines
AU2002252773A1 (en) Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
AU6159001A (en) Vaccines, immunotherapeutics and methods for using the same
AU2002303093A1 (en) Mycobacterial vaccines
AU2002253038A1 (en) Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof
AU2003289640A1 (en) Tricyclacetalactonin, Preparation and Use there of
WO2002099718A8 (fr) Systeme et procedes de configuration
AU2002302785A1 (en) Vaccines
AU2001244831A1 (en) 3-cyclopentyloxy-4-methoxyphenyl-isoindolinone derivatives and the use thereof
AU2001244832A1 (en) 3-cyclopentyloxy-4-methoxyphenyl-isothiazolinone derivatives and the use thereof
AU2002317616A1 (en) Alumina-zirconia, and methods of making and using the same
AU2002250998B2 (en) Caloporoside derivatives, methods for the production thereof and their use
HK1069982A (en) Vaccine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase